Plus, news about Vericel:
AN2 Therapeutics adopts poison pill: The small molecule drugmaker put forth the stockholder rights plan for a year after one of its investors — BML Investment Partners — quickly bought up the biotech’s stock. The firm holds about 19.3% of the biotech’s common stock. — Kyle LaHucik
Pfizer’s flu shots show promise in Phase 2: The company’s second-generation trivalent vaccine candidates produced “robust” responses against influenza A and B compared with an approved flu vaccine. The Phase 2 test enrolled 450 people aged 18 to 64. On Friday, Pfizer also shared that its combined flu and Covid vaccine missed one of two key primary endpoints in a Phase 3 trial. — Ayisha Sharma
Vericel’s FDA approval: The company’s severe thermal burn treatment gained regulatory clearance for pediatric patients. Known as NexoBrid, it was initially approved for adults in December 2022. — Kyle LaHucik